Let it be, long last this it !!, page-109

The rise in price likely reflects the confidence of share holders and market participants in the imminent
future prospects of the Company and this belief that the Company is currently undervalued.
In particular, recent milestones reported by the company include:
a)The imminent expected grant of a Mining Development License (MDL) on our flagship South Johnstone bauxite project;

b)The application by our controlled entity Medical Cannabis Limited (MCL) for a Medical Cannabis Research License from the Office of Drug Control and MCL’s strategic position, contacts and exper tise in the medical cannabis industry;

c) The change in legislation that will make hemp permissible for human consumption in Australia beginning in
November of this year, and the strategic positioning of MCL through its Vitahemp brand to become the premier quality Australian supplier to the Australian and global markets, using MCL’s current granted censes to grow low THC Cannabis; and significantly,

d) the recent announcement of the securing of over 20 tonnes of low THC Cannabis super seed to be planted in the up coming planting season, which in layman terms effectively means the company, through its current licenses,has the capacity to grow well over 1200 acres (approximately 600 hectares) of low THC Cannabis to be able to supply thelocal and global market with hemp products following the legalisation of hemp for human consumption in Australia to take effect in November.

Strategic alliances are being currently formed with various prominent farmers to enable the company to plant this significant size of grow in the upcoming season.

These reported milestones are the reasons we believe the share price of the company is deeply undervalued.